Literature DB >> 12403006

Involvement of the nucleus accumbens in stimulation of the immune response in rats after activation of opioid mu receptors with DAGO.

L V Devoino1, M A Cheido, E L Al'perina.   

Abstract

The involvement of the nucleus accumbens in neuroimmunostimulation was demonstrated during activation of opioid mu receptors with the selective agonist DAGO (100 microg/kg); single doses of this agent to sham-operated (control) Wistar rats induced significant increases in the numbers of direct IgM antibody-forming and total rosette-forming cells after immunization with sheep erythrocytes. Bilateral electrolytic lesioning of the nucleus accumbens in rats led to sharp decreases in the intensity of immune responses; there was no immunostimulation after administration of DAGO to these animals. These data provide evidence for the involvement of the nucleus accumbens in the process of immunomodulation and for the importance of opioid mu receptors in the nucleus accumbens in the stimulation of immunogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403006     DOI: 10.1023/a:1019815824348

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  32 in total

1.  Involvement of delta-opioid receptors in immunosuppression.

Authors:  M Cheido; G Idova; L Devoino
Journal:  Int J Neurosci       Date:  1996-02       Impact factor: 2.292

2.  Reward produced by microinjection of (D-Ala2),Met5-enkephalinamide into the ventral tegmental area.

Authors:  A G Phillips; F G LePiane
Journal:  Behav Brain Res       Date:  1982-06       Impact factor: 3.332

3.  Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat: evidence for a pre-synaptic locus.

Authors:  N R Swerdlow; M Amalric; G F Koob
Journal:  Pharmacol Biochem Behav       Date:  1987-04       Impact factor: 3.533

4.  A method of increased sensitivity for detecting single antibody-forming cells.

Authors:  A J Cunningham
Journal:  Nature       Date:  1965-09-04       Impact factor: 49.962

5.  Immunomodulatory action of class mu-, delta- and kappa-opioid receptor agonists in mice.

Authors:  J Kowalski
Journal:  Neuropeptides       Date:  1998-08       Impact factor: 3.286

6.  Involvement of opioid mu1-receptors in opioid-induced acceleration of striatal and limbic dopaminergic transmission.

Authors:  T P Piepponen; A Honkanen; T Kivastik; A Zharkovsky; A Turtia; J A Mikkola; L Ahtee
Journal:  Pharmacol Biochem Behav       Date:  1999-06       Impact factor: 3.533

7.  Involvement of brain dopaminergic structures in neuroimmunomodulation.

Authors:  L Devoino; E Alperina; O Galkina; R Ilyutchenok
Journal:  Int J Neurosci       Date:  1997-10       Impact factor: 2.292

8.  Opposing activities of brain opioid receptors in the regulation of humoral and cell-mediated immune responses in the rat.

Authors:  J Radulović; B D Janković
Journal:  Brain Res       Date:  1994-10-24       Impact factor: 3.252

9.  Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats.

Authors:  G Di Chiara; A Imperato
Journal:  J Pharmacol Exp Ther       Date:  1988-03       Impact factor: 4.030

Review 10.  Pharmacological studies on the interrelation between the dopaminergic, GABAergic and opioid peptidergic systems in the central nervous system of the rat.

Authors:  K Kamata
Journal:  Jpn J Pharmacol       Date:  1987-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.